Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Feb 15;101(4):769–776. doi: 10.1172/JCI480

Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine.

G A Rongen 1, S C Brooks 1, S i Ando 1, B L Abramson 1, J S Floras 1
PMCID: PMC508624  PMID: 9466971

Abstract

We tested the hypothesis that endogenous angiotensin II participates in the direct and reflex effects of adenosine on the sympathetic nervous system. Nine healthy men were studied after 1 wk of the angiotensin II type I receptor antagonist losartan (100 mg daily) or placebo, according to a double-blind randomized crossover design. Bilateral forearm blood flows, NE appearance rates, and total body NE spillover were determined before and during graded brachial arterial infusion of adenosine (0.5, 1.5, 5, and 15 microg/100 ml forearm tissue) and nitroprusside. Adenosine increased total body NE spillover (P < 0.05) whereas nitroprusside did not. Losartan lowered BP (P < 0.05), had no effect on total body NE spillover at rest, or forearm vasodilation during either infusion, but reduced the systemic noradrenergic response to adenosine from 1.0+/-0.4 nmol/min on the placebo day to 0.2+/-0.3 nmol/min (P < 0.01), and forearm NE appearance rate in response to adenosine was lower in the infused, as compared with the contralateral arm (P = 0.04). The sympatho-excitatory reflex elicited by adenosine is mediated through pathways involving the angiotensin II type I receptor. Interactions between adenosine and angiotensin II may assume importance during ischemia or congestive heart failure and could contribute to the benefit of converting enzyme inhibition in these conditions.

Full Text

The Full Text of this article is available as a PDF (178.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiken J. W., Reit E. Stimulation of the cat stellate ganglion by angiotensin. J Pharmacol Exp Ther. 1968 Jan;159(1):107–114. [PubMed] [Google Scholar]
  2. Ambrosioni E., Borghi C., Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med. 1995 Jan 12;332(2):80–85. doi: 10.1056/NEJM199501123320203. [DOI] [PubMed] [Google Scholar]
  3. Anderson E. A., Wallin B. G., Mark A. L. Dissociation of sympathetic nerve activity in arm and leg muscle during mental stress. Hypertension. 1987 Jun;9(6 Pt 2):III114–III119. doi: 10.1161/01.hyp.9.6_pt_2.iii114. [DOI] [PubMed] [Google Scholar]
  4. Ando S., Dajani H. R., Floras J. S. Frequency domain characteristics of muscle sympathetic nerve activity in heart failure and healthy humans. Am J Physiol. 1997 Jul;273(1 Pt 2):R205–R212. doi: 10.1152/ajpregu.1997.273.1.R205. [DOI] [PubMed] [Google Scholar]
  5. Ando S., Dajani H. R., Senn B. L., Newton G. E., Floras J. S. Sympathetic alternans. Evidence for arterial baroreflex control of muscle sympathetic nerve activity in congestive heart failure. Circulation. 1997 Jan 21;95(2):316–319. doi: 10.1161/01.cir.95.2.316. [DOI] [PubMed] [Google Scholar]
  6. Aneman A., Eisenhofer G., Olbe L., Dalenbäck J., Nitescu P., Fändriks L., Friberg P. Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepinephrine spillover. J Clin Invest. 1996 Apr 1;97(7):1640–1646. doi: 10.1172/JCI118590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Biaggioni I. Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. Hypertension. 1992 Oct;20(4):457–465. doi: 10.1161/01.hyp.20.4.457. [DOI] [PubMed] [Google Scholar]
  8. Biaggioni I., Killian T. J., Mosqueda-Garcia R., Robertson R. M., Robertson D. Adenosine increases sympathetic nerve traffic in humans. Circulation. 1991 May;83(5):1668–1675. doi: 10.1161/01.cir.83.5.1668. [DOI] [PubMed] [Google Scholar]
  9. Biaggioni I., Olafsson B., Robertson R. M., Hollister A. S., Robertson D. Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res. 1987 Dec;61(6):779–786. doi: 10.1161/01.res.61.6.779. [DOI] [PubMed] [Google Scholar]
  10. Chang P. C., Kriek E., van Brummelen P. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension. J Hypertens. 1994 Feb;12(2):179–190. [PubMed] [Google Scholar]
  11. Clemson B., Gaul L., Gubin S. S., Campsey D. M., McConville J., Nussberger J., Zelis R. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J Clin Invest. 1994 Feb;93(2):684–691. doi: 10.1172/JCI117021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cockcroft J. R., O'Kane K. P., Webb D. J. Tissue angiotensin generation and regulation of vascular tone. Pharmacol Ther. 1995 Feb;65(2):193–213. doi: 10.1016/0163-7258(94)00062-8. [DOI] [PubMed] [Google Scholar]
  13. Costa F., Biaggioni I. Adenosine activates afferent fibers in the forearm, producing sympathetic stimulation in humans. J Pharmacol Exp Ther. 1993 Dec;267(3):1369–1374. [PubMed] [Google Scholar]
  14. Costa F., Biaggioni I. Role of adenosine in the sympathetic activation produced by isometric exercise in humans. J Clin Invest. 1994 Apr;93(4):1654–1660. doi: 10.1172/JCI117147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cox D. A., Vita J. A., Treasure C. B., Fish R. D., Selwyn A. P., Ganz P. Reflex increase in blood pressure during the intracoronary administration of adenosine in man. J Clin Invest. 1989 Aug;84(2):592–596. doi: 10.1172/JCI114203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Edlund A., Ohlsén H., Sollevi A. Renal effects of local infusion of adenosine in man. Clin Sci (Lond) 1994 Aug;87(2):143–149. doi: 10.1042/cs0870143. [DOI] [PubMed] [Google Scholar]
  17. Ely S. W., Berne R. M. Protective effects of adenosine in myocardial ischemia. Circulation. 1992 Mar;85(3):893–904. doi: 10.1161/01.cir.85.3.893. [DOI] [PubMed] [Google Scholar]
  18. Esler M., Jennings G., Korner P., Willett I., Dudley F., Hasking G., Anderson W., Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension. 1988 Jan;11(1):3–20. doi: 10.1161/01.hyp.11.1.3. [DOI] [PubMed] [Google Scholar]
  19. Funaya H., Kitakaze M., Node K., Minamino T., Komamura K., Hori M. Plasma adenosine levels increase in patients with chronic heart failure. Circulation. 1997 Mar 18;95(6):1363–1365. doi: 10.1161/01.cir.95.6.1363. [DOI] [PubMed] [Google Scholar]
  20. Grossman E., Chang P. C., Hoffman A., Tamrat M., Kopin I. J., Goldstein D. S. Tracer norepinephrine kinetics: dependence on regional blood flow and the site of infusion. Am J Physiol. 1991 May;260(5 Pt 2):R946–R952. doi: 10.1152/ajpregu.1991.260.5.R946. [DOI] [PubMed] [Google Scholar]
  21. Hisatome I., Ishiko R., Miyakoda H., Saito M., Kitamura H., Kinugawa T., Kobayashi M., Kotake H., Mashiba H., Sato R. Excess purine degradation caused by an imbalance in the supply of adenosine triphosphate in patients with congestive heart failure. Br Heart J. 1990 Dec;64(6):359–361. doi: 10.1136/hrt.64.6.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jacobsen T. N., Lange R. A., Olivari M. T., Yancy C. W., Horn V. P., Ring W. S., Baldwin B. J., Cooley R. A., Victor R. G. Differential reflex control of forearm and calf resistance vessels by chemosensitive cardiac afferent activation. J Appl Physiol (1985) 1994 Mar;76(3):1123–1129. doi: 10.1152/jappl.1994.76.3.1123. [DOI] [PubMed] [Google Scholar]
  23. Julius S. Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension. 1993 Jun;21(6 Pt 2):886–893. doi: 10.1161/01.hyp.21.6.886. [DOI] [PubMed] [Google Scholar]
  24. Katholi R. E., Hageman G. R., Whitlow P. L., Woods W. T. Hemodynamic and afferent renal nerve responses to intrarenal adenosine in the dog. Hypertension. 1983 Mar-Apr;5(2 Pt 2):I149–I154. doi: 10.1161/01.hyp.5.2_pt_2.i149. [DOI] [PubMed] [Google Scholar]
  25. Kaye D. M., Lefkovits J., Jennings G. L., Bergin P., Broughton A., Esler M. D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995 Nov 1;26(5):1257–1263. doi: 10.1016/0735-1097(95)00332-0. [DOI] [PubMed] [Google Scholar]
  26. Latini R., Maggioni A. P., Flather M., Sleight P., Tognoni G. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation. 1995 Nov 15;92(10):3132–3137. doi: 10.1161/01.cir.92.10.3132. [DOI] [PubMed] [Google Scholar]
  27. Lenders J., Janssen G. J., Smits P., Thien T. Role of the wrist cuff in forearm plethysmography. Clin Sci (Lond) 1991 May;80(5):413–417. doi: 10.1042/cs0800413. [DOI] [PubMed] [Google Scholar]
  28. Matthews J. N., Altman D. G., Campbell M. J., Royston P. Analysis of serial measurements in medical research. BMJ. 1990 Jan 27;300(6719):230–235. doi: 10.1136/bmj.300.6719.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Middlekauff H. R., Nitzsche E. U., Nguyen A. H., Hoh C. K., Gibbs G. G. Modulation of renal cortical blood flow during static exercise in humans. Circ Res. 1997 Jan;80(1):62–68. doi: 10.1161/01.res.80.1.62. [DOI] [PubMed] [Google Scholar]
  30. Newman W. H., Grossman S. J., Frankis M. B., Webb J. G. Increased myocardial adenosine release in heart failure. J Mol Cell Cardiol. 1984 Jun;16(6):577–580. doi: 10.1016/s0022-2828(84)80645-8. [DOI] [PubMed] [Google Scholar]
  31. Newton G. E., Tong J. H., Schofield A. M., Baines A. D., Floras J. S., Parker J. D. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J Am Coll Cardiol. 1996 Jul;28(1):155–161. doi: 10.1016/0735-1097(96)00120-9. [DOI] [PubMed] [Google Scholar]
  32. Pang C. Y., Yang R. Z., Zhong A., Xu N., Boyd B., Forrest C. R. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res. 1995 Jun;29(6):782–788. [PubMed] [Google Scholar]
  33. Reid I. A. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992 Jun;262(6 Pt 1):E763–E778. doi: 10.1152/ajpendo.1992.262.6.E763. [DOI] [PubMed] [Google Scholar]
  34. Richardt G., Waas W., Kranzhöfer R., Mayer E., Schömig A. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res. 1987 Jul;61(1):117–123. doi: 10.1161/01.res.61.1.117. [DOI] [PubMed] [Google Scholar]
  35. Rongen G. A., Floras J. S., Lenders J. W., Thien T., Smits P. Cardiovascular pharmacology of purines. Clin Sci (Lond) 1997 Jan;92(1):13–24. doi: 10.1042/cs0920013. [DOI] [PubMed] [Google Scholar]
  36. Rongen G. A., Lenders J. W., Lambrou J., Willemsen J. J., Van Belle H., Thien T., Smits P. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension. 1996 Apr;27(4):933–938. doi: 10.1161/01.hyp.27.4.933. [DOI] [PubMed] [Google Scholar]
  37. Rongen G. A., Senn B. L., Ando S., Notarius C. F., Stone J. A., Floras J. S. Comparison of hemodynamic and sympathoneural responses to adenosine and lower body negative pressure in man. Can J Physiol Pharmacol. 1997 Feb;75(2):128–134. [PubMed] [Google Scholar]
  38. Rongen G. A., Smits P., Ver Donck K., Willemsen J. J., De Abreu R. A., Van Belle H., Thien T. Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection. J Clin Invest. 1995 Feb;95(2):658–668. doi: 10.1172/JCI117711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Smits G. J., Kitzen J. M., Perrone M. H., Cox B. F. Angiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilation. Hypertension. 1993 Aug;22(2):221–230. doi: 10.1161/01.hyp.22.2.221. [DOI] [PubMed] [Google Scholar]
  40. Smits P., Lenders J. W., Thien T. Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther. 1990 Oct;48(4):410–418. doi: 10.1038/clpt.1990.169. [DOI] [PubMed] [Google Scholar]
  41. Song K. F., Zhuo J. L., Mendelsohn F. A. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors. Br J Pharmacol. 1991 Dec;104(4):771–772. doi: 10.1111/j.1476-5381.1991.tb12503.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Taddei S., Favilla S., Duranti P., Simonini N., Salvetti A. Vascular renin-angiotensin system and neurotransmission in hypertensive persons. Hypertension. 1991 Sep;18(3):266–277. doi: 10.1161/01.hyp.18.3.266. [DOI] [PubMed] [Google Scholar]
  43. Taddei S., Virdis A., Favilla S., Salvetti A. Adenosine activates a vascular renin-angiotensin system in hypertensive subjects. Hypertension. 1992 Jun;19(6 Pt 2):672–675. doi: 10.1161/01.hyp.19.6.672. [DOI] [PubMed] [Google Scholar]
  44. Thames M. D., Kinugawa T., Dibner-Dunlap M. E. Reflex sympathoexcitation by cardiac sympathetic afferents during myocardial ischemia. Role of adenosine. Circulation. 1993 May;87(5):1698–1704. doi: 10.1161/01.cir.87.5.1698. [DOI] [PubMed] [Google Scholar]
  45. Thornton J. D., Liu G. S., Olsson R. A., Downey J. M. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation. 1992 Feb;85(2):659–665. doi: 10.1161/01.cir.85.2.659. [DOI] [PubMed] [Google Scholar]
  46. Tsuchida A., Miura T., Miki T., Shimamoto K., Iimura O. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res. 1992 May;26(5):456–461. doi: 10.1093/cvr/26.5.456. [DOI] [PubMed] [Google Scholar]
  47. Wallin B. G., Victor R. G., Mark A. L. Sympathetic outflow to resting muscles during static handgrip and postcontraction muscle ischemia. Am J Physiol. 1989 Jan;256(1 Pt 2):H105–H110. doi: 10.1152/ajpheart.1989.256.1.H105. [DOI] [PubMed] [Google Scholar]
  48. Watt A. H., Reid P. G., Stephens M. R., Routledge P. A. Adenosine-induced respiratory stimulation in man depends on site of infusion. Evidence for an action on the carotid body? Br J Clin Pharmacol. 1987 Apr;23(4):486–490. doi: 10.1111/j.1365-2125.1987.tb03081.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wong P. C., Hart S. D., Zaspel A. M., Chiu A. T., Ardecky R. J., Smith R. D., Timmermans P. B. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther. 1990 Nov;255(2):584–592. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES